IMU should never had a MC of $3.5B and entered the ASX 200, it was a biotech start-up stock with an IP which wasn't even close to Ph2 completion. The market way overvalue the MC then and has undervalue the MC now, the only thing investor can do is what for clinical trial update, those taking about revenue and commercialisation are clearly ramping the stock.
Media Thread, page-14186
-
- There are more pages in this discussion • 1,929 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 94526 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 22000 | 2 |
View Market Depth
| Last trade - 09.41am 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable